CoDa Therapeutics (United States)

Recent papers from CoDa Therapeutics (United States)

1. A simplicial homology approach for assessing and rectifying coverage of sensor networks for improved crop managementEuropean Journal of Operational Research · 2025
2. The dual endothelin A and angiotensin II type 1 receptor antagonist sparsentan (FILSPARI®) exhibits a safe nonclinical male fertility toxicity profileRegulatory Toxicology and Pharmacology · 2024
3. Cancer Moonshot: Moonshot as a Magic Code to Guide Successful Solutions of Tough Challenges Such as CancerInternational Journal of Research in Oncology · 2023
4. Decoding degeneration: the implementation of machine learning for clinical detection of neurodegenerative disordersNeural Regeneration Research · 2022
5. “It's my frenemy”: A qualitative exploration of knowledge and perceptions of fentanyl use during the COVID-19 pandemic in people who use drugs at a syringe services program in Philadelphia, PAFrontiers in Public Health · 2022
6. Counselor Turnover in Substance Use Disorder Treatment Research: Observations from One Multisite TrialSubstance Abuse · 2019
7. The Future of Science and Science of the Future: Vision and Strategy for the African Open Science Platform (v02)2018
8. Turning FAIR data into reality: interim report from the European Commission Expert Group on FAIR data2018
9. Lessons Learned from the Implementation of A Medically Enhanced Residential Treatment (Mert) Model Integrating Intravenous Antibiotics and Residential Addiction TreatmentSubstance Abuse · 2018
10. Planning and Designing the Improving Addiction Care Team (IMPACT) for Hospitalized Adults with Substance Use DisorderJournal of Hospital Medicine · 2017
11. Gender differences among treatment-seeking adults with cannabis use disorder: Clinical profiles of women and men enrolled in the achieving cannabis cessation-evaluating N-acetylcysteine treatment (ACCENT) studyAmerican Journal on Addictions · 2017
12. Connexin gap junction channels and chronic rhinosinusitisInternational Forum of Allergy & Rhinology · 2016
13. Referencing Data In Publications: Principles, Policy And Practice: Presentations2016
14. Long‐term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi‐site trialAddiction · 2015
15. Abnormal connexin expression in human chronic woundsBritish Journal of Dermatology · 2015
16. Massage Impact on Pain in Opioid-dependent Patients in Substance Use TreatmentInternational Journal of Therapeutic Massage & Bodywork Research Education & Practice · 2015
17. Patient Perspectives on Buprenorphine/Naloxone: A Qualitative Study of Retention During the Starting Treatment with Agonist Replacement Therapies (START) StudyJournal of Psychoactive Drugs · 2014
18. Pain and Emotional Distress Among Substance-Use Patients Beginning Treatment Relative to a Representative Comparison GroupJournal of Addiction Medicine · 2014
19. Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi‐site trialAddiction · 2013
20. Buprenorphine/Naloxone and Methadone Maintenance Treatment Outcomes for Opioid Analgesic, Heroin, and Combined Users: Findings From Starting Treatment With Agonist Replacement Therapies (START)Journal of Studies on Alcohol and Drugs · 2013